If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
479.40    1.40 (0.29%)
Bid:
481.20
Ask:
482.00
Spread: 0.80 (0.166%)
Market Cap: £2.46b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

QinetiQ Group plc First Quarter Trading Update

18 Jul 2024 07:00

RNS Number : 8293W
QinetiQ Group plc
18 July 2024
 

News release

QinetiQ Group plc

First Quarter Trading Update

18 July 2024 - QinetiQ Group plc ("QinetiQ" or the "Group") today issues a trading update covering its first quarter to 30 June 2024.

On-track to deliver FY25 expectations - good first quarter performance

Operational performance in the first quarter has been good and we remain on-track to deliver high single digit organic revenue growth at stable margin with good cash conversion, in line with our FY25 guidance. Order intake performance was good with revenue under contract for the full year increasing to 73%, up from 64% at April 2024.

As part of our continued focus on disciplined capital allocation, our £100m share buyback programme is on-track to be completed in the financial year with £32m shares purchased by the end of the first quarter.

Steve Wadey, Group Chief Executive Officer said:

"I am pleased that we have delivered a good start to the year, with performance for the first quarter in line with our expectations and attractive shareholder returns. The relevance and demand for our services and products remains high in the elevated threat environment, as we continue to focus on consistent operational delivery for our customers and disciplined capital allocation. These three factors underpin our confidence in delivering our FY27 target of c.£2.4bn of organic revenue at c.12% margin and compelling value for our shareholders."

Good operational performance in EMEA Services

EMEA Services continues to deliver good operational performance with revenue growth in line with our expectations. Our long-term contracts, such as Engineering Delivery Partner in the UK and Major Service Provider in Australia, continue to perform well for our customers. We have also won a new framework contract for NATO customers to utilise our Test & Evaluation services in the UK provided under the Long Term Partnering Agreement.

Strong order intake in Global Solutions

Global Solutions delivered strong order intake with revenue performance in line with our expectations. In the US, we have won a contract to be the sole source provider of the survivability solution for the long-term Future Long Range Assault Aircraft (FLRAA) programme, with our Light-appliqué Armour Systems Technology. Through good delivery performance on our Tethered Aerostat Radar System contract we have also won an initial 10% growth in contract value, and we are continuing to realise the benefits of our integrated US platform by winning framework contracts with two new National Security customers.

Board Changes and AGM

As announced on 16th April 2024, Martin Cooper has been appointed as Group CFO. We are pleased to confirm that Martin will join QinetiQ at the start of September, sooner than originally anticipated.

QinetiQ's 2024 Annual General Meeting (AGM) will be held at 11am on Thursday 18th July at Ashurst LLP, London Fruit & Wool Exchange, 1 Duval Square, London E1 6PW.

About QinetiQ

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs circa 8,500 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

For further information please contact:

Stephen Lamacraft, Group Interim Director Investor Relations: +44 (0) 7471 885817

Lindsay Walls, Group Director Communications (Media enquiries) +44 (0) 7793 427582

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLRDDIDLIS
Date   Source Headline
2nd Jul 20264:35 pmRNSDirector/PDMR Shareholding
2nd Jul 202612:02 pmRNSHolding(s) in Company
30th Jun 20262:07 pmRNSTotal Voting Rights
30th Jun 20267:00 amRNSTransaction in Own Shares
24th Jun 20263:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20267:00 amRNSTransaction in Own Shares
17th Jun 20265:01 pmRNSHolding(s) in Company
16th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20265:09 pmRNSDirector/PDMR Shareholding
10th Jun 202611:05 amRNSAnnual Financial Report
9th Jun 20265:00 pmRNSHolding(s) in Company
9th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20266:00 pmRNSHolding(s) in Company
2nd Jun 20267:00 amRNSTransaction in Own Shares
29th May 20264:45 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSQinetiQ Full Year Results 2026
20th May 20264:16 pmRNSHolding(s) in Company
19th May 20264:00 pmRNSHolding(s) in Company
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20264:57 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20269:46 amRNSTransaction in Own Shares
30th Apr 20263:10 pmRNSTotal Voting Rights
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20261:38 pmRNSDirector Declaration
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 202612:00 pmRNSDirector/PDMR Shareholding
7th Apr 202610:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSDirector/PDMR Shareholding
31st Mar 20263:01 pmRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 202611:39 amRNSHolding(s) in Company
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 202612:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.